Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beta-3 adrenergic receptor overexpression reverses aortic stenosis-induced heart failure and restores balanced mitochondrial dynamics.
Pun-García A, Clemente-Moragón A, Villena-Gutierrez R, Gómez M, Sanz-Rosa D, Díaz-Guerra A, Prados B, Medina JP, Montó F, Ivorra MD, Márquez-López C, Cannavo A, Bernal JA, Koch WJ, Fuster V, de la Pompa JL, Oliver E, Ibanez B. Pun-García A, et al. Among authors: fuster v. Basic Res Cardiol. 2022 Nov 29;117(1):62. doi: 10.1007/s00395-022-00966-z. Basic Res Cardiol. 2022. PMID: 36445563 Free PMC article.
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial.
García-Álvarez A, Blanco I, García-Lunar I, Jordà P, Rodriguez-Arias JJ, Fernández-Friera L, Zegri I, Nuche J, Gomez-Bueno M, Prat S, Pujadas S, Sole-Gonzalez E, Garcia-Cossio MD, Rivas M, Torrecilla E, Pereda D, Sanchez J, García-Pavía P, Segovia-Cubero J, Delgado JF, Mirabet S, Fuster V, Barberá JA, Ibañez B; SPHERE-HF Investigators. García-Álvarez A, et al. Among authors: fuster v. Eur J Heart Fail. 2023 Mar;25(3):373-385. doi: 10.1002/ejhf.2745. Epub 2022 Dec 4. Eur J Heart Fail. 2023. PMID: 36404400 Free article. Clinical Trial.
Oral anticoagulants: A plausible new treatment for Alzheimer's disease?
Toribio-Fernandez R, Ceron C, Tristão-Pereira C, Fernandez-Nueda I, Perez-Castillo A, Fernandez-Ferro J, Moro MA, Ibañez B, Fuster V, Cortes-Canteli M. Toribio-Fernandez R, et al. Among authors: fuster v. Br J Pharmacol. 2024 Mar;181(6):760-776. doi: 10.1111/bph.16032. Epub 2023 Jan 31. Br J Pharmacol. 2024. PMID: 36633908 Review.
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis.
Iglesies-Grau J, Garcia-Alvarez A, Oliva B, Mendieta G, García-Lunar I, Fuster JJ, Devesa A, Pérez-Herreras C, Fernández-Ortiz A, Brugada R, Ibanez B, Fernandez-Jimenez R, Fuster V. Iglesies-Grau J, et al. Among authors: fuster jj, fuster v. Cardiovasc Diabetol. 2023 Dec 19;22(1):350. doi: 10.1186/s12933-023-02090-1. Cardiovasc Diabetol. 2023. PMID: 38115031 Free PMC article.
Metabolic changes contribute to maladaptive right ventricular hypertrophy in pulmonary hypertension beyond pressure overload: an integrative imaging and omics investigation.
García-Lunar I, Jorge I, Sáiz J, Solanes N, Dantas AP, Rodríguez-Arias JJ, Ascaso M, Galán-Arriola C, Jiménez FR, Sandoval E, Nuche J, Moran-Garrido M, Camafeita E, Rigol M, Sánchez-Gonzalez J, Fuster V, Vázquez J, Barbas C, Ibáñez B, Pereda D, García-Álvarez A. García-Lunar I, et al. Among authors: fuster v. Basic Res Cardiol. 2024 Mar 27. doi: 10.1007/s00395-024-01041-5. Online ahead of print. Basic Res Cardiol. 2024. PMID: 38536505
Magnetic resonance imaging reference values for cardiac morphology, function and tissue composition in adolescents.
Real C, Párraga R, Pizarro G, García-Lunar I, González-Calvo E, Martínez-Gómez J, Sánchez-González J, Sampedro P, Sanmamed I, De Miguel M, De Cos-Gandoy A, Bodega P, Ibanez B, Santos-Beneit G, Fuster V, Fernández-Jiménez R. Real C, et al. Among authors: fuster v. EClinicalMedicine. 2023 Mar 3;57:101885. doi: 10.1016/j.eclinm.2023.101885. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 37064511 Free PMC article.
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study.
Tristão-Pereira C, Fuster V, Oliva B, Moreno-Arciniegas A, Garcia-Lunar I, Perez-Herreras C, Schöll M, Suárez-Calvet M, Moro MA, Garcia-Alvarez A, Fernandez-Ortiz A, Sanchez-Gonzalez J, Zetterberg H, Blennow K, Ibanez B, Gispert JD, Cortes-Canteli M. Tristão-Pereira C, et al. Among authors: fuster v. Lancet Healthy Longev. 2023 Sep;4(9):e487-e498. doi: 10.1016/S2666-7568(23)00134-4. Lancet Healthy Longev. 2023. PMID: 37659430 Free PMC article.
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.
Devesa A, Fuster V, Vazirani R, García-Lunar I, Oliva B, España S, Moreno-Arciniegas A, Sanz J, Perez-Herreras C, Bueno H, Lara-Pezzi E, García-Alvarez A, de Vega VM, Fernández-Friera L, Trivieri MG, Fernández-Ortiz A, Rossello X, Sanchez-Gonzalez J, Ibanez B. Devesa A, et al. Among authors: fuster v. Diabetes Care. 2023 Nov 1;46(11):2050-2057. doi: 10.2337/dc23-0871. Diabetes Care. 2023. PMID: 37713581 Free PMC article.
Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study.
Toribio-Fernández R, Tristão-Pereira C, Carlos Silla-Castro J, Callejas S, Oliva B, Fernandez-Nueda I, Garcia-Lunar I, Perez-Herreras C, María Ordovás J, Martin P, Blanco-Kelly F, Ayuso C, Lara-Pezzi E, Fernandez-Ortiz A, Garcia-Alvarez A, Dopazo A, Sanchez-Cabo F, Ibanez B, Cortes-Canteli M, Fuster V. Toribio-Fernández R, et al. Among authors: fuster v. Circ Res. 2024 Feb 16;134(4):411-424. doi: 10.1161/CIRCRESAHA.123.323921. Epub 2024 Jan 23. Circ Res. 2024. PMID: 38258600 Free article.
1,568 results